lutein has been researched along with Hyperglycemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, R; Maradagi, T; Ponesakki, G | 1 |
| Ponesakki, G; Sharan, K; Shivarudrappa, AH | 1 |
| Nanjaiah, H; Vallikannan, B | 2 |
| Baskaran, V; Joseph, GS; Sharavana, G | 1 |
| Arnal, E; Barcia, J; Bosch-Morell, F; Miranda, M; Romero, FJ | 1 |
6 other study(ies) available for lutein and Hyperglycemia
| Article | Year |
|---|---|
Hyperglycaemia-induced human hepatocellular carcinoma (HepG2) cell proliferation through ROS-mediated P38 activation is effectively inhibited by a xanthophyll carotenoid, lutein.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Hep G2 Cells; Humans; Hyperglycemia; Liver Neoplasms; Lutein; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Xanthophylls | 2022 |
Lutein activates downstream signaling pathways of unfolded protein response in hyperglycemic ARPE-19 cells.
Topics: Activating Transcription Factor 4; Activating Transcription Factor 6; Biological Factors; Cell Line; Endoplasmic Reticulum Stress; Endoribonucleases; Gene Expression Regulation; Humans; Hyperglycemia; Lutein; Macula Lutea; Oxidative Stress; Protective Agents; Protein Serine-Threonine Kinases; Signal Transduction; Unfolded Protein Response; X-Box Binding Protein 1 | 2022 |
Lutein upregulates the PGC-1α, NRF1, and TFAM expression by AMPK activation and downregulates ROS to maintain mtDNA integrity and mitochondrial biogenesis in hyperglycemic ARPE-19 cells and rat retina.
Topics: AMP-Activated Protein Kinases; Animals; Cell Survival; Cells, Cultured; DNA-Binding Proteins; DNA, Mitochondrial; Down-Regulation; Humans; Hyperglycemia; Lutein; Male; Mitochondria; Mitochondrial Proteins; Nuclear Respiratory Factor 1; Optical Imaging; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Wistar; Reactive Oxygen Species; Retina; Transcription Factors; Up-Regulation | 2019 |
Enhanced phosphorylation of AMPK by lutein and oxidised lutein that lead to mitochondrial biogenesis in hyperglycemic HepG2 cells.
Topics: AMP-Activated Protein Kinases; Biomarkers, Tumor; Cell Survival; Endocytosis; Gene Expression Regulation, Neoplastic; Gluconeogenesis; Hep G2 Cells; Humans; Hyperglycemia; Inflammation Mediators; Lipid Metabolism; Lutein; Mitochondria; Models, Molecular; NADH Dehydrogenase; Organelle Biogenesis; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphorylation; Reactive Oxygen Species; RNA, Messenger; Superoxide Dismutase-1; Triglycerides | 2019 |
Lutein attenuates oxidative stress markers and ameliorates glucose homeostasis through polyol pathway in heart and kidney of STZ-induced hyperglycemic rat model.
Topics: Aldehyde Reductase; Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Heart; Homeostasis; Hyperglycemia; Kidney; L-Iditol 2-Dehydrogenase; Lutein; Male; Malondialdehyde; Oxidative Stress; Polymers; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2017 |
Lutein and docosahexaenoic acid prevent cortex lipid peroxidation in streptozotocin-induced diabetic rat cerebral cortex.
Topics: Aldehydes; Animals; Antigens, Nuclear; Antioxidants; Biomarkers; Brain Diseases, Metabolic; Cerebral Cortex; Diabetes Complications; Diabetes Mellitus, Experimental; Disease Models, Animal; Docosahexaenoic Acids; Drug Therapy, Combination; Fluorescent Antibody Technique; Glucose; Glutathione; Glutathione Peroxidase; Hyperglycemia; Insulin; Lipid Peroxidation; Lutein; Male; Malondialdehyde; Nerve Tissue Proteins; Oxidative Stress; Rats; Rats, Wistar; Treatment Outcome | 2010 |